According to a Form 8-K released on May 3rd, 2018, OWC Pharmaceutical Corp (OWCP) has received a $5 million investment from an Institutional Investor. On April 30, 2018, OWC Pharmaceutical Research Corp. (the “Registrant”) entered into and consummated a Securities Purchase Agreement (the “Agreement”)…

For anybody curious, this is just a quick post to share an update I came across after signing up for “PACER” (https://pacer.psc.uscourts.gov) in order to access the public records in the court system. There was an update for Jeffrey Friedland’s case on 4/20/18…

In case you didn’t listen to the whole interview or just didn’t pay close enough attention, I felt it necessary to point out the key takeaways. Dr. Hirsch spent most of the video talking about medical cannabis in general, the research aspect, and…

On February 18, 2018, OWC Pharmaceutical Research Corp appointed Dr. Oron Yacoby Zeevi as its Chief Scientific Officer (CSO) and Dr. Yehuda Baruch, who was OWC’s CSO, will now serve as Chief Medical and Regulatory Officer. Brief Intro via 8K Filing: Dr. Oron…

It’s been a while since I’ve had any time to sit down and write. So, thought I would give it a try today with OWCP. After all, I am still “Long” here and Bullish overall. All shareholders are well aware of the deafening…

As I was scrolling through LinkedIn tonight, I saw something shared by a long time due diligence writer, Roland Rick Perry. It was a comment made by another man who is simply listed as “Investor” on his own LinkedIn page. His post said:…

I saw the “Novel Cannabis Condom” patent application circulating online the last few days, as it made its way to the US PTO (Patent & Trademark Office) website finally. This patent application was originally submitted and back in December 2015 and was showing…

It was ‘discovered’ that OWCP had updated their Investor Presentation and published it on their website in the past few days — and it had some nice, juicy updates that are creating some joy for many shareholders. Allow me to break down what…

I felt it was time for an update as to “where I stand” since I’ve had dozens of messages (e-mail, Twitter, InvestorsHangout.com, etc.) over the past week or two asking my thoughts on OWCP now that it’s November and we haven’t heard since…

Once again, Yossi Dagan is submitting Amended SEC Filings. Using a PDF compare tool from Draftable.com, I quickly found there were no real changes to the actual document (other than the dates and the fact that Yossi has now checked the box that said…